DocGo (NASDAQ:DCGO) Cut to “Strong Sell” at Zacks Research

Zacks Research downgraded shares of DocGo (NASDAQ:DCGO) from a hold rating to a strong sell rating in a research report released on Tuesday morning,Zacks.com reports.

Several other analysts have also commented on DCGO. Canaccord Genuity Group raised their target price on DocGo from $1.45 to $1.60 and gave the stock a “hold” rating in a report on Thursday, August 21st. Weiss Ratings reaffirmed a “sell (d)” rating on shares of DocGo in a report on Wednesday. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $3.24.

DocGo Stock Performance

Shares of DCGO stock opened at $1.20 on Tuesday. The stock’s 50-day simple moving average is $1.50 and its 200-day simple moving average is $1.71. The firm has a market capitalization of $117.37 million, a PE ratio of -6.32 and a beta of 0.95. DocGo has a fifty-two week low of $1.19 and a fifty-two week high of $5.68.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.05). The firm had revenue of $80.42 million during the quarter, compared to analyst estimates of $77.58 million. DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. DocGo has set its FY 2025 guidance at EPS. Sell-side analysts forecast that DocGo will post 0.25 earnings per share for the current year.

Hedge Funds Weigh In On DocGo

A number of hedge funds have recently bought and sold shares of the business. State of Wyoming boosted its position in DocGo by 113.3% during the second quarter. State of Wyoming now owns 264,793 shares of the company’s stock worth $416,000 after purchasing an additional 140,670 shares in the last quarter. Oxford Asset Management LLP boosted its position in DocGo by 122.6% during the second quarter. Oxford Asset Management LLP now owns 93,126 shares of the company’s stock worth $146,000 after purchasing an additional 51,298 shares in the last quarter. Engineers Gate Manager LP purchased a new position in DocGo during the second quarter worth approximately $52,000. Boothbay Fund Management LLC boosted its position in DocGo by 512.6% during the second quarter. Boothbay Fund Management LLC now owns 185,690 shares of the company’s stock worth $292,000 after purchasing an additional 155,379 shares in the last quarter. Finally, Bridgeway Capital Management LLC boosted its position in DocGo by 19.3% during the second quarter. Bridgeway Capital Management LLC now owns 357,757 shares of the company’s stock worth $562,000 after purchasing an additional 57,757 shares in the last quarter. Hedge funds and other institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.